Error! You must javascript enabled to use this form. Please enable Javascript in your browser. Investigation Announced for Long-Term Investors in Mirati Therapeutics, Inc. (NASDAQ:MRTX) Certain directors of Mirati Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties. View full press release Your Name: Your Email: Subject: Question: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send